Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease.
暂无分享,去创建一个
J. Lewis | W. Sandborn | J. Colombel | R. Thakkar | P. Pollack | Bidan Huang | M. Osterman | A. Robinson | Winnie Lau
暂无分享,去创建一个
J. Lewis | W. Sandborn | J. Colombel | R. Thakkar | P. Pollack | Bidan Huang | M. Osterman | A. Robinson | Winnie Lau